pharma · Duchenne Muscular Dystrophy · Muscular Dystrophy, Duchenne · SRPT
Sarepta Therapeutics
Sarepta Therapeutics clinical programs — 14 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 215 First Street, Cambridge, MA 02142, US
- Employees
- 1,150
- Programs
- 46
- Drugs
- 23
- Patents
- 102
Sarepta Therapeutics projects
14 ClinicalTrials.gov programs sponsored by Sarepta Therapeutics.
Sarepta Therapeutics has 14 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
AVI-4020 Injection
Sarepta Therapeutics
West Nile Fever
1 trial -
AVI-4020 Injection
Sarepta Therapeutics
West Nile Virus
1 trial -
AVI-4065 Injection
Sarepta Therapeutics
Encephalitis
1 trial -
AVI-4126 Injection (RESTEN-NG®)
Sarepta Therapeutics
Neoplasms
1 trial -
AVI-6003
Sarepta Therapeutics
Marburg Hemorrhagic Fever
1 trial -
AVI-7100
Sarepta Therapeutics
Influenza
1 trial -
AVI-7288
Sarepta Therapeutics
Marburg Hemorrhagic Fever
1 trial -
AVI-7537
Sarepta Therapeutics
Ebola Hemorrhagic Fever
1 trial -
Placebo
Sarepta Therapeutics
Ebola Hemorrhagic Fever
1 trial -
SRP-1005
Sarepta Therapeutics
Huntington's Disease
1 trial -
SRP-6004
Sarepta Therapeutics
Limb Girdle Muscular Dystrophy
1 trial -
SRP-9001-104
Sarepta Therapeutics
Duchenne muscular dystrophy (DMD)
1 trial -
SRP-9004
Sarepta Therapeutics
Limb Girdle Muscular Dystrophy
1 trial -
rAAVrh74.MHCK7.DYSF.DV
Sarepta Therapeutics
Dysferlinopathy
1 trial
Frequently asked questions
How many clinical projects does Sarepta Therapeutics have?
14 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.